MainReads
← Details
Ex vivo JAK and TNF inhibitor-modulated immune signatures guide first-line therapy selection in rheumatoid arthritis.
Corrales S, Pérez-Sánchez C, Cerdó T, Merlo C, Malvar-Fernández B, García S, Muñoz-Barrera L, Sanchez-Pareja I, Formanti L, Moreno-Caño E, Ortega-Castro R, Calvo J, Aranda-Varela C, Ladehesa L, Font P, Abalos-Aguilera MC, Ruiz-Vilchez D, Aguirre MÁ, Barbarroja N, Alarcon-Riquelme ME, Escudero-Contreras A, López-Pedrera C
/
-
Loading document from repository...
Unable to Display Document
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.